OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 02, 2017
Industry experts were honored for business, scientific, and social contributions.
October 25, 2017
Catalent’s new Biologics & Specialty Drug Delivery unit will be led by Barry Littlejohn; Jonathan Arnold to lead Oral Drug Delivery.
The M&A advisory firm has developed an interactive map of manufacturing sites to give insight into the market size of global manufacturing.
October 24, 2017
The CDMO is investing £6 million into a new facility at its United Kingdom site to expand its milling, micronization, and solid form capabilities.
October 20, 2017
The company has announced that it has acquired a new bioanalysis and biomarkers services facility in Laval, Montreal, Canada to support preclinical and clinical programs.
October 18, 2017
The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.
October 17, 2017
CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site
October 16, 2017
The companies will collaborate to produce and improve the recombinant properties of Aethlon’s Hemopurifier blood purification device.
Piramal is investing $55 million into the expansion of its API manufacturing capabilities and capacities across sites in North America and Asia.
October 14, 2017
Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.